184 related articles for article (PubMed ID: 23369209)
21. The microRNA-451a/chromosome segregation 1-like axis suppresses cell proliferation, migration, and invasion and induces apoptosis in nasopharyngeal carcinoma.
Luo Y; Qu X; Kan D; Cai B
Bioengineered; 2021 Dec; 12(1):6967-6980. PubMed ID: 34516344
[TBL] [Abstract][Full Text] [Related]
22. CSE1L interaction with MSH6 promotes osteosarcoma progression and predicts poor patient survival.
Cheng DD; Lin HC; Li SJ; Yao M; Yang QC; Fan CY
Sci Rep; 2017 Apr; 7():46238. PubMed ID: 28387323
[TBL] [Abstract][Full Text] [Related]
23. Early decline in serum phospho-CSE1L levels in vemurafenib/sunitinib-treated melanoma and sorafenib/lapatinib-treated colorectal tumor xenografts.
Lee WR; Shen SC; Shih YH; Chou CL; Tseng JT; Chin SY; Liu KH; Chen YC; Jiang MC
J Transl Med; 2015 Jun; 13():191. PubMed ID: 26070816
[TBL] [Abstract][Full Text] [Related]
24. High nuclear expression of phosphorylated extracellular signal-regulated kinase in tumor cells in colorectal glands is associated with poor outcome in colorectal cancer.
Tai CJ; Lee CH; Chen HC; Wang HK; Jiang MC; Su TC; Shen KH; Lin SH; Yeh CM; Chen CJ; Yeh KT; Chang CC
Ann Diagn Pathol; 2013 Apr; 17(2):165-71. PubMed ID: 23183114
[TBL] [Abstract][Full Text] [Related]
25. Cytoplasmic, nuclear, and total PBK/TOPK expression is associated with prognosis in colorectal cancer patients: A retrospective analysis based on immunohistochemistry stain of tissue microarrays.
Su TC; Chen CY; Tsai WC; Hsu HT; Yen HH; Sung WW; Chen CJ
PLoS One; 2018; 13(10):e0204866. PubMed ID: 30286126
[TBL] [Abstract][Full Text] [Related]
26. The nuclear to cytoplasmic shift of ING5 protein during colorectal carcinogenesis with their distinct links to pathologic behaviors of carcinomas.
Zheng HC; Xia P; Xu XY; Takahashi H; Takano Y
Hum Pathol; 2011 Mar; 42(3):424-33. PubMed ID: 21193223
[TBL] [Abstract][Full Text] [Related]
27. Cytoplasmic accumulation of p53 protein: an independent prognostic indicator in colorectal adenocarcinomas.
Bosari S; Viale G; Bossi P; Maggioni M; Coggi G; Murray JJ; Lee AK
J Natl Cancer Inst; 1994 May; 86(9):681-7. PubMed ID: 8158699
[TBL] [Abstract][Full Text] [Related]
28. CSE1L silence inhibits the growth and metastasis in gastric cancer by repressing GPNMB via positively regulating transcription factor MITF.
Li Y; Yuan S; Liu J; Wang Y; Zhang Y; Chen X; Si W
J Cell Physiol; 2020 Mar; 235(3):2071-2079. PubMed ID: 31347172
[TBL] [Abstract][Full Text] [Related]
29. Expression of CAS/CSE1L, the Cellular Apoptosis Susceptibility Protein, Correlates With Neoplastic Progression in Barrett's Esophagus.
Jiang K; Neill K; Cowden D; Klapman J; Eschrich S; Pimiento J; Malafa MP; Coppola D
Appl Immunohistochem Mol Morphol; 2018 Sep; 26(8):552-556. PubMed ID: 27941559
[TBL] [Abstract][Full Text] [Related]
30. MIR-137 suppresses growth and invasion, is downregulated in oligodendroglial tumors and targets CSE1L.
Li KK; Yang L; Pang JC; Chan AK; Zhou L; Mao Y; Wang Y; Lau KM; Poon WS; Shi Z; Ng HK
Brain Pathol; 2013 Jul; 23(4):426-39. PubMed ID: 23252729
[TBL] [Abstract][Full Text] [Related]
31. Cytoplasmic mislocalization of overexpressed FOXF1 is associated with the malignancy and metastasis of colorectal adenocarcinomas.
Lo PK; Lee JS; Chen H; Reisman D; Berger FG; Sukumar S
Exp Mol Pathol; 2013 Feb; 94(1):262-9. PubMed ID: 23103611
[TBL] [Abstract][Full Text] [Related]
32. Suppression of cellular apoptosis susceptibility (CSE1L) inhibits proliferation and induces apoptosis in colorectal cancer cells.
Zhu JH; Hong DF; Song YM; Sun LF; Wang ZF; Wang JW
Asian Pac J Cancer Prev; 2013; 14(2):1017-21. PubMed ID: 23621178
[TBL] [Abstract][Full Text] [Related]
33. CSE1L Links cAMP/PKA and Ras/ERK pathways and regulates the expressions and phosphorylations of ERK1/2, CREB, and MITF in melanoma cells.
Lee WR; Shen SC; Wu PR; Chou CL; Shih YH; Yeh CM; Yeh KT; Jiang MC
Mol Carcinog; 2016 Nov; 55(11):1542-1552. PubMed ID: 26331446
[TBL] [Abstract][Full Text] [Related]
34. Re-expression of CEACAM1 long cytoplasmic domain isoform is associated with invasion and migration of colorectal cancer.
Ieda J; Yokoyama S; Tamura K; Takifuji K; Hotta T; Matsuda K; Oku Y; Nasu T; Kiriyama S; Yamamoto N; Nakamura Y; Shively JE; Yamaue H
Int J Cancer; 2011 Sep; 129(6):1351-61. PubMed ID: 21413011
[TBL] [Abstract][Full Text] [Related]
35. [Relationship between PUMA and BIM expression in colorectal cancer and tumor invasion, metastasis and prognosis].
Yuan H; Tu SL; He XJ
Zhonghua Wai Ke Za Zhi; 2013 Jun; 51(6):547-51. PubMed ID: 24091272
[TBL] [Abstract][Full Text] [Related]
36. High level of Notch1 protein is associated with poor overall survival in colorectal cancer.
Chu D; Li Y; Wang W; Zhao Q; Li J; Lu Y; Li M; Dong G; Zhang H; Xie H; Ji G
Ann Surg Oncol; 2010 May; 17(5):1337-42. PubMed ID: 20058190
[TBL] [Abstract][Full Text] [Related]
37. Circ_cse1l Inhibits Colorectal Cancer Proliferation by Binding to eIF4A3.
Xu B; Yang N; Liu Y; Kong P; Han M; Li B
Med Sci Monit; 2020 Aug; 26():e923876. PubMed ID: 32857753
[TBL] [Abstract][Full Text] [Related]
38. CAS (CSE1L) signaling pathway in tumor progression and its potential as a biomarker and target for targeted therapy.
Jiang MC
Tumour Biol; 2016 Oct; 37(10):13077-13090. PubMed ID: 27596143
[TBL] [Abstract][Full Text] [Related]
39. RhoE is associated with relapse and prognosis of patients with colorectal cancer.
Zhou J; Yang J; Li K; Mo P; Feng B; Wang X; Nie Y; Fan D
Ann Surg Oncol; 2013 Jan; 20(1):175-82. PubMed ID: 22941156
[TBL] [Abstract][Full Text] [Related]
40. Syndecan-1 expression is associated with tumor size and EGFR expression in colorectal carcinoma: a clinicopathological study of 230 cases.
Kim SY; Choi EJ; Yun JA; Jung ES; Oh ST; Kim JG; Kang WK; Lee SH
Int J Med Sci; 2015; 12(2):92-9. PubMed ID: 25589885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
